Ancient DNA From Eurasian Herders Sheds Light on the Origins of Multiple Sclerosis
January 14, 2014 Genetic variants linked to the risk of MS were brought to Europe during a migration around 5,000…
Blood levels of GFAP protein may predict disease progression in PPMS
Risk of disability worsening nearly 3 times greater with high GFAP: Study The ongoing worsening of disability among people with primary…
Stuart Schlossman
EU agency OKs study of therapy to improve mitochondrial function
Trial of MP101 to enroll patients with MS, other neurodegenerative diseases by Andrea Lobo, PhD | January 16, 2024 Mitochon Pharmaceuticals is launching a…
Stuart Schlossman
Disease activity and neonatal outcomes after exposure to natalizumab throughout pregnancy
Abstract Background: After natalizumab discontinuation severe relapses can occur despite pregnancy, but third trimester exposure is associated with neonatal haematological…
Stuart Schlossman
NK cells may hold key to link between viral infections, MS
Multiple risk factors, antibodies against EBV and myelin lead to high MS riskby Marisa Wexler, MS | December 15, 2023…
Stuart Schlossman
New study suggests possible targets for multiple sclerosis vaccine development
Published December 15, 2023 | Originally published on MedicalXpress Breaking News-and-Events Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease in which the Epstein-Barr…
Stuart Schlossman
U.S. Neurologists Eagerly Await Promising Oral BTKis in MS Treatment Pipeline, Though Recent Trial Readouts Might Hamper Initial Excitement
Efficacy and safety of pipeline multiple sclerosis assets viewed as increasingly important characteristics, according to Spherix Global Insights. [Exton PA, December 13,…
Stuart Schlossman
Potential drug targets for multiple sclerosis identified through Mendelian randomization analysis
Abstract Multiple sclerosis is a complex autoimmune disease, and several therapies for multiple sclerosis have been developed and widely used.…
Stuart Schlossman
Pediatric Onset Multiple Sclerosis and Obesity: Defining the Silhouette of Disease Features in Overweight Patients
December 2023 Abstract Obesity has been suggested as an environmental risk factor for multiple sclerosis (MS) and may negatively…
Stuart Schlossman
“Inverse vaccine” shows potential to treat multiple sclerosis and other autoimmune diseases
September 11, 2023 In a new study, Prof. Jeffrey Hubbell and fellow researchers describe a new “inverse vaccine” that in…
Stuart Schlossman
